6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18705079 | VALBENAZINE COMPOSITIONS | LIU, TRACY | 1614 | Non-Final OA | Apr 26, 2024 |
| 18286935 | METHODS FOR THE COMBINED ADMINISTRATION OF DEUTETRABENAZINE AND A CYP2D6 INHIBITOR | NESTOR, DONNA MICHELLE | 1627 | Non-Final OA | Oct 13, 2023 |
| 18286944 | METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS | NESTOR, DONNA MICHELLE | 1627 | Non-Final OA | Oct 13, 2023 |
| 18042748 | CRF RECEPTOR ANTAGONISTS AND METHODS OF USE | HASTINGS, ALISON AZAR | 1627 | Final Rejection | Feb 23, 2023 |
| 17797368 | MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE | WILSON, JERICA KATLYNN | 1621 | Final Rejection | Aug 03, 2022 |
| 16105396 | Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis | RODRIGUEZ, RAYNA B | 1628 | Final Rejection | Aug 20, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial